Results

Total Results: 426 records

Showing results for "design sample size".

301. Primary Care–Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/VpT-c4bnmvHFRPyKgPwb2Z
     December 01, 2010 - was reduced in 1 trial of first cataract surgery Medication assessment and withdrawal 1 (47) Small sample … size (48 participants) NA NA Fair Limited evidence of no benefit Fall risk was not reported Home-hazard … Author Contributions: Conception and design: Y.L. Michael, E.P. Whitlock, J.S. Lin, E.A. O’Connor. … Articles excluded for KQ 1 (n = 225) Relevance: 97 Setting: 24 Population: 17 Quality: 18 Study design … Articles excluded for KQ 4 (n = 329) Relevance: 112 Setting: 35 Population: 27 Quality: 23 Study design

302. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - Included Studies: Aspirin Chemoprevention of Colonic Adenomas and Colorectal Cancer, by Study Design* … Its design, conduct, and reporting were based on specific directives from these agencies. … The Women's Health Study maintained the RCT design for the entire study period. … Not an eligible study design = 135. Unable to obtain = 2." … Included Studies: Aspirin Chemoprevention of Colonic Adenomas and Colorectal Cancer, by Study Design*

303. Evidence Summary: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/cervical-cancer-screening
     August 21, 2018 - in countries with organized screening programs such that even large trials did not have sufficient sample … size or duration to detect changes in invasive cervical cancer incidence, CIN 3 or worse (CIN 3+) was … Summary tables of study design, population characteristics, protocols, and intervention and follow-up … Design: Study did not use an included design. Language: Publication not in English. … Source Study Design

304. Archived: Evidence Summary: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
     September 25, 2012 - Sample sizes ranged from 72 to 1559, and study durations ranged from 6 to 48 months Appendix Table 3

305. Evidence Summary: Pregnant Women: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-pregnant-women1/human-immunodeficiency-virus-hiv-infection-screening
     June 11, 2019 - Sample sizes ranged from 183 to 13,124 (total n = 71,472). … vs 3.2%, P = 0.43) or stillbirth. 9 Methodological limitations of the trial included open-label design … pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design … No. of Studies; No. of Participants; Study Design

306. Depression and Suicide Risk Screening: Updated Evidence Summary and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
     September 09, 2021 - excluded for KQ3 9 Intervention 7 Population 7 Setting 4 Aim 34 Outcomes 3 Comparator 2 Quality 2 Design … for KQ4 31 Intervention 136 Population 89 Setting 5 Aim 104 Outcomes 19 Comparator 44 Quality 69 Design … for KQ5 30 Intervention 134 Population 89 Setting 6 Aim 267 Outcomes 22 Comparator 43 Quality 57 Design … Design: Study did not use an included design. … Concept and design: All authors.

307. Archived: Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
     November 15, 2012 - Data Extraction and Quality Assessment One investigator abstracted details about the study design … Methodologic shortcomings included open-label design 55 or high attrition 22 . … Sizes, I Cirrhosis at Baseline, % Elevated Aminotransferase Levels at Baseline, % Genotype Mix … § More than 2 times the upper limit of normal. || Sample sizes and results are restricted to patients … Sizes, n Cirrhosis, % Elevated Aminotransferase Levels, % Boceprevir or Telaprevir

308. Archived: Final Evidence Summary: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
     December 15, 2010 - cataract surgery Single clinical treatment: Medication assessment and withdrawal 1 47 Small sample … size (48 participants) NA NA Fair Limited evidence of no benefit Fall risk was not reported … Reasons for exclusion were: relevance (n=97); setting (n=24); population (n=17); quality (n=18); study design … Reasons for exclusion were: relevance (n=112); setting (n=35); population (n=27); quality (n=23); study design … Reasons for exclusion were: relevance (n=5); population (n=2); quality (n=2); study design (n=18); outcomes

309. Uhtgkzvs Bpnj4 G4Fxuay (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uhtgkZVs_bpNJ4_G4fXUay
     March 01, 2014 - Evidence is insufficient because of: the limited number or size of studies; important flaws in study design

310. Archived: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening-2014
     June 23, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Abdominal Aortic Aneurysm: Screening June 23, 2014 Recommendations made by the USPSTF are independent of the U.S. government.…

311. Archived: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     January 10, 2017 - The newer studies are more subject to design issues than the older ones, which had fewer design flaws … ethnicity. 20 These inconsistent results among Hispanic women could be a result of chance due to small sample … sizes.

312. Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/r9MoffF79edExY5m2V_koD
     May 01, 2021 - Abstraction and Quality Rating A single investigator abstracted details from each study including study design … in Iran29,40,48,49; the others were conducted in Hong Kong,24 Australia,34 or Europe.23,28,37,41 Sample … sizes ranged from 52 to 12 513 participants (total n = 23 844). … Four studies had more than 1000 participants; 3 were added for this update, had the largest sample sizes … Concept and design: Cantor, Bougatsos, DeLoughery, Chou.

313. Screening for Depression in Children and Adolescents: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kAg43FLUnTjCU5ZNaaHQtW
     March 01, 2016 - Evidence is insufficient because of: the limited number or size of studies; important flaws in study design

314. peds20151711 1..8 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/72ybMHDdg9WyFzrYMBF4ch
     August 01, 2015 - In addition to small sample sizes, some studies were conducted in countries with health care systems

315. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvDjnZzW9PDxzKBauB4QxA
     August 21, 2018 - in countries with organized screening programs such that even large trials did not have sufficient sample … size or duration to detect changes in invasive cervical cancer incidence, CIN 3 or worse (CIN 3+) was … Summary tables of study design, population charac- teristics, protocols, and intervention and follow-up … Design: Study did not use an included design. Language: Publication not in English. … Concept and design: Melnikow, Henderson, Burda, Senger.

316. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
     September 06, 2016 - Extraction and Quality Assessment For each included study, one investigator extracted information about design … unlikely to be clinically relevant and can be explained by the number of included studies with large sample … sizes and precise estimates, a phenomenon that has been described as producing elevated I 2 estimates … comparator(s), 63 for ineligible or no outcome(s), 8 for ineligible setting, 36 for ineligible study design … Key Question No. of Studies No. of Participants Study Design

317. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
     March 01, 2007 - The PICOS (participant, intervention/exposure, comparator, outcome and study design) approach was applied … Its design, con- duct, and reporting were based on specific directives from these agencies. … These RCTs shared many sim- ilarities, and the strength of their design adds weight to these negative … The Women’s Health Study maintained the RCT design for the entire study period. … Included Studies: Aspirin Chemoprevention of Colonic Adenomas and Colorectal Cancer, by Study Design*

318. Archived: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
     July 07, 2015 - In addition to small sample sizes, some studies were conducted in countries with health care systems

319. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/efwy72cuMdhcF2jotkhTzC
     March 29, 2019 - Evidence is insufficient because of the limited number or size of studies. important flaws in study design … HIV-Infected Adults (TEMPRANO ANRS) trial (n = 2056)30—and 3 large fair-quality cohort studies, ranging in sample … size from 3532 to 55 826 (total n = 63 478),31-33 that provided evidence on the benefits of early initiation … pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design

320. Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ERAa_Bwr7hQxqZZ-X3p8Qh
     May 10, 2022 - While no consistent benefit was seen among these trials it is unclear if and how small sample sizes, … Concept and design: Webber, Lin. Acquisition, analysis, or interpretation of data: All authors.